Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4145 | 1762 | 30.5 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EXTRANODAL NK T CELL LYMPHOMA | Author keyword | 86 | 76% | 3% | 60 |
2 | NK T CELL LYMPHOMA | Author keyword | 80 | 70% | 4% | 67 |
3 | NASAL LYMPHOMA | Author keyword | 67 | 85% | 2% | 35 |
4 | BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM | Author keyword | 57 | 78% | 2% | 38 |
5 | EXTRANODAL NATURAL KILLER T CELL LYMPHOMA | Author keyword | 56 | 85% | 2% | 29 |
6 | NATURAL KILLER CELL LYMPHOMA | Author keyword | 54 | 83% | 2% | 30 |
7 | CHRONIC ACTIVE EPSTEIN BARR VIRUS INFECTION | Author keyword | 52 | 77% | 2% | 36 |
8 | LETHAL MIDLINE GRANULOMA | Author keyword | 47 | 84% | 1% | 26 |
9 | NASAL TYPE | Author keyword | 46 | 73% | 2% | 35 |
10 | HYPERSENSITIVITY TO MOSQUITO BITES | Author keyword | 44 | 100% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LETHAL MIDLINE GRANULOMA | 163 | 77% | 6% | 112 |
2 | NASAL TYPE | 151 | 69% | 7% | 128 |
3 | POLYMORPHIC RETICULOSIS | 142 | 79% | 5% | 92 |
4 | ANGIOCENTRIC LYMPHOMA | 99 | 88% | 3% | 46 |
5 | NK T CELL LYMPHOMA | 85 | 79% | 3% | 54 |
6 | NATURAL KILLER T CELL | 79 | 91% | 2% | 32 |
7 | CD4CD56HEMATODERMIC NEOPLASMS | 57 | 95% | 1% | 19 |
8 | NASAL LYMPHOMAS | 47 | 88% | 1% | 22 |
9 | PRECURSOR ACUTE LEUKEMIA | 46 | 72% | 2% | 36 |
10 | LINEAGE NEGATIVE MALIGNANCIES | 45 | 94% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
How I treat NK/T-cell lymphomas | 2013 | 26 | 69 | 93% |
Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders | 2014 | 6 | 101 | 81% |
Natural killer-cell malignancies: diagnosis and treatment | 2005 | 120 | 73 | 82% |
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation | 2013 | 12 | 31 | 94% |
Blastic Plasmacytoid Dendritic Cell Neoplasm A Clinicopathologic Review | 2014 | 4 | 17 | 94% |
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review | 2012 | 19 | 19 | 95% |
What is CD4+CD56+malignancy and how should it be treated? | 2003 | 64 | 38 | 95% |
EBV-associated Cutaneous NK/T-cell Lymphoma Review of a Series of 14 Cases From Peru in Children and Young Adults | 2010 | 30 | 56 | 77% |
Natural killer cell neoplasms | 2008 | 46 | 87 | 85% |
Progress in understanding and managing natural killer-cell malignancies | 2007 | 64 | 87 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP ETUD IMMUNOL LEUCEMIES | 2 | 67% | 0.1% | 2 |
2 | PATHOL C3 | 2 | 18% | 0.5% | 9 |
3 | RADIAT ONCOLBRAIN KOREA PROJECT MED SCI 21 | 1 | 50% | 0.1% | 2 |
4 | YONSEI CANC SEODAEMOON GU | 1 | 100% | 0.1% | 2 |
5 | HSCT DATA MANAGEMENT | 1 | 20% | 0.3% | 6 |
6 | VIROL IMMUNOLBUNKYO KU | 1 | 30% | 0.2% | 3 |
7 | LYMPHOMA REGISTRY | 1 | 40% | 0.1% | 2 |
8 | IMMUNOHISTOCHEM UNIT | 1 | 25% | 0.2% | 3 |
9 | HSCT DATA MANAGEMENT BIOSTAT | 1 | 13% | 0.3% | 6 |
10 | VIROLBUNKYO KU | 1 | 33% | 0.1% | 2 |
Related classes at same level (level 1) |